FDA finds contamination in heparin samples
Patient Safety Monitor Alert, March 12, 2008
Want to receive articles like this one in your inbox? Subscribe to Patient Safety Monitor Alert!
The Food and Drug Administration (FDA) found 5% to 20% of heparin samples distributed by Baxter International to be contaminated, reports The Boston Globe. The number of deaths associated with this contaminant rose from four to 19, though it's not certain that the causes of death are specifically related to the contaminated heparin. Much of the heparin used in the U.S. is manufactured in China, says the FDA, and an investigation is being launched into whether the contaminated heparin was created by faulty manufacturing, or purposely to reduce costs.
Heparin, used to treat blood clots, is produced from pig intestines and creates $30 million in profit for Baxter.
To read the article, click here
Want to receive articles like this one in your inbox? Subscribe to Patient Safety Monitor Alert!
Comments
0 comments on “FDA finds contamination in heparin samples ”
Related Products
Most Popular
- Articles
-
- HIPAA Q&A: Answering service messages
- Featured blog post: Nurses face felony charges after reporting physician to the Texas Medical Board
- Q&A: Coding for dry skin due to cold weather
- Q/A: Volume requirement for reporting hydration services
- Are your workforce members texting PHI?
- Topic: CMS, OESS post new security compliance review information, checklist
- What does case-mix index mean to you?
- Privacy, security concerns high in HIEs
- QA:Coding multiple initial infusions
- OB services: Coding inside and outside of the package
- E-mailed
-
- Featured blog post: Nurses face felony charges after reporting physician to the Texas Medical Board
- Q/A: Volume requirement for reporting hydration services
- HIPAA Q&A: Level of encryption needed for email
- HIPAA Q&A: Answering service messages
- HIPAA Q&A: TPO disclosures to a business associate
- Are your workforce members texting PHI?
- Q&A: Coding for dry skin due to cold weather
- Hospitalist-surgeon comanagement has no effect on outcomes
- Don't let these sentinel events trigger falsely
- Correctly bill ancillary bedside procedures in addition to the room rate
- Searched
